Holen Sie sich die Stockscreener-App
3.30
3.45%
0.11
Handel nachbörslich:
3.40
0.10
+3.03%
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.002 | 0.004 | - |
Operating Expenses
|
14.24%
1.187
|
1.039 | 1.094 | 0.759 | 1.15 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
14.04%
1.186
|
1.04 | 1.094 | 0.759 | 1.15 |
| Operating Income/Loss |
14.24%
-1.187
|
-1.039 | -1.092 | -0.755 | -1.15 |
| Nonoperating Income/Loss |
333.33%
0.028
|
-0.012 | 0.019 | 0.013 | 0.023 |
| Income/Loss From Continuing Operations Before Tax |
10.28%
-1.159
|
-1.051 | 0.002 | 0.004 | -1.127 |
| Income/Loss From Continuing Operations After Tax |
10.28%
-1.159
|
-1.051 | -1.073 | -0.742 | -1.127 |
|
Net Income/Loss
|
10.28%
-1.159
|
-1.051 | -1.073 | -0.742 | -1.127 |
| Preferred Stock Dividends And Other Adjustments |
0.042
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
30.23%
2.183
|
1.6763 | 1.6013 | - | 1.6013 |
| Diluted Average Shares |
30.23%
2.183
|
1.6763 | 1.6013 | - | 1.6013 |
| Basic Earnings Per Share |
12.70%
-0.55
|
-0.63 | -0.67 | -0.46 | -0.70 |
| Diluted Earnings Per Share |
12.70%
-0.55
|
-0.63 | -0.67 | -0.46 | -0.70 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.042
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):